In the past week, ZVSA stock has gone up by 4.72%, with a monthly decline of -23.75% and a quarterly plunge of -6.14%. The volatility ratio for the week is 9.28%, and the volatility levels for the last 30 days are 9.03% for ZyVersa Therapeutics Inc The simple moving average for the past 20 days is -11.24% for ZVSA’s stock, with a -78.76% simple moving average for the past 200 days.
Is It Worth Investing in ZyVersa Therapeutics Inc (NASDAQ: ZVSA) Right Now?
The 36-month beta value for ZVSA is at 0.63. Analysts have varying views on the stock, with 0 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for ZVSA is 7.51M, and currently, shorts hold a 7.73% of that float. The average trading volume for ZVSA on April 25, 2024 was 2.48M shares.
ZVSA) stock’s latest price update
The stock price of ZyVersa Therapeutics Inc (NASDAQ: ZVSA) has surged by 8.41 when compared to previous closing price of 0.56, but the company has seen a 4.72% gain in its stock price over the last five trading sessions. PennyStocks reported 2024-02-27 that Investing in penny stocks offers a unique opportunity for investors looking to expand their portfolios with potentially high-reward options. Recognized for their affordability, these stocks allow individuals to purchase shares in emerging companies without a significant financial outlay.
ZVSA Trading at -19.74% from the 50-Day Moving Average
After a stumble in the market that brought ZVSA to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -99.33% of loss for the given period.
Volatility was left at 9.03%, however, over the last 30 days, the volatility rate increased by 9.28%, as shares sank -18.57% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +2.69% upper at present.
During the last 5 trading sessions, ZVSA rose by +4.72%, which changed the moving average for the period of 200-days by -93.54% in comparison to the 20-day moving average, which settled at $0.6803. In addition, ZyVersa Therapeutics Inc saw -32.22% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for ZVSA
The total capital return value is set at -8.02. Equity return is now at value -177.00, with -139.81 for asset returns.
Based on ZyVersa Therapeutics Inc (ZVSA), the company’s capital structure generated 0.0 points at debt to capital in total, while cash flow to debt ratio is standing at -1007.49. The debt to equity ratio resting at 0.0. The interest coverage ratio of the stock is 172555.92.
Currently, EBITDA for the company is -14.41 million with net debt to EBITDA at -0.05. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.33.
Conclusion
In conclusion, ZyVersa Therapeutics Inc (ZVSA) has had a bad performance lately. Opinion on the stock among analysts is mixed, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
